Epidemiological profile and north-south gradient driving baseline systemic involvement of primary Sjögren's syndrome.


Journal

Rheumatology (Oxford, England)
ISSN: 1462-0332
Titre abrégé: Rheumatology (Oxford)
Pays: England
ID NLM: 100883501

Informations de publication

Date de publication:
01 09 2020
Historique:
received: 12 07 2019
revised: 27 10 2019
pubmed: 25 12 2019
medline: 20 1 2021
entrez: 25 12 2019
Statut: ppublish

Résumé

To characterize the systemic phenotype of primary Sjögren's syndrome at diagnosis by analysing the EULAR-SS disease activity index (ESSDAI) scores. The Sjögren Big Data Consortium is an international, multicentre registry based on worldwide data-sharing cooperative merging of pre-existing databases from leading centres in clinical research in Sjögren's syndrome from the five continents. The cohort included 10 007 patients (9352 female, mean 53 years) with recorded ESSDAI scores available. At diagnosis, the mean total ESSDAI score was 6.1; 81.8% of patients had systemic activity (ESSDAI score ≥1). Males had a higher mean ESSDAI (8.1 vs 6.0, P < 0.001) compared with females, as did patients diagnosed at <35 years (6.7 vs 5.6 in patients diagnosed at >65 years, P < 0.001). The highest global ESSDAI score was reported in Black/African Americans, followed by White, Asian and Hispanic patients (6.7, 6.5, 5.4 and 4.8, respectively; P < 0.001). The frequency of involvement of each systemic organ also differed between ethnic groups, with Black/African American patients showing the highest frequencies in the lymphadenopathy, articular, peripheral nervous system, CNS and biological domains, White patients in the glandular, cutaneous and muscular domains, Asian patients in the pulmonary, renal and haematological domains and Hispanic patients in the constitutional domain. Systemic activity measured by the ESSDAI, clinical ESSDAI (clinESSDAI) and disease activity states was higher in patients from southern countries (P < 0.001). The systemic phenotype of primary Sjögren's syndrome is strongly influenced by personal determinants such as age, gender, ethnicity and place of residence, which are key geoepidemiological players in driving the expression of systemic disease at diagnosis.

Identifiants

pubmed: 31873754
pii: 5686418
doi: 10.1093/rheumatology/kez578
doi:

Types de publication

Journal Article Multicenter Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2350-2359

Subventions

Organisme : Medical Research Council
ID : G0800629
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/J002720/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/N003063/1
Pays : United Kingdom

Informations de copyright

© The Author(s) 2019. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Auteurs

Pilar Brito-Zerón (P)

Department of Medicine, Autoimmune Diseases Unit, Hospital CIMA - Sanitas, Barcelona, Spain.
Sjögren Syndrome Research Group (AGAUR), Laboratory of Autoimmune Diseases Josep Font, IDIBAPS-CELLEX, Department of Autoimmune Diseases, ICMiD, University of Barcelona, Hospital Clínic, Barcelona, Spain.

Nihan Acar-Denizli (N)

Department of Statistics, Faculty of Science and Letters, Mimar Sinan Fine Arts University, Istanbul, Turkey.

Wan-Fai Ng (WF)

Institute of Cellular Medicine, Newcastle University, NIHR Biomedical Research Centre, Newcastle Upon Tyne, UK.

Ildiko Fanny Horváth (IF)

Division of Clinical Immunology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.

Astrid Rasmussen (A)

Arthritis and Clinical Immunology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, USA.

Raphaele Seror (R)

Center for Immunology of Viral Infections and Autoimmune Diseases, Assistance Publique - Hôpitaux de Paris, Hôpitaux Universitaires Paris-Sud, Le Kremlin-Bicêtre, Université Paris Sud, INSERM, Paris, France.

Xiaomei Li (X)

Department of Rheumatology and Immunology, Anhui Provincial Hospital, Hefei, China.

Chiara Baldini (C)

Rheumatology Unit, University of Pisa, Pisa, Italy.

Jacques-Eric Gottenberg (JE)

Department of Rheumatology, Strasbourg University Hospital, Université de Strasbourg, CNRS, Strasbourg, France.

Debashish Danda (D)

Department of Clinical Immunology & Rheumatology, Christian Medical College & Hospital, Vellore, India.

Luca Quartuccio (L)

Clinic of Rheumatology, Department of Medical Area, University Hospital 'Santa Maria della Misericordia', Udine, Italy.

Roberta Priori (R)

Department of Internal Medicine and Medical Specialties, Rheumatology Clinic, Sapienza University of Rome, Rome, Italy.

Gabriela Hernandez-Molina (G)

Immunology and Rheumatology Department, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, México City, Mexico.

Berkan Armagan (B)

Department of Internal Medicine, Hacettepe University, Faculty of Medicine, Ankara, Turkey.

Aike A Kruize (AA)

Department of Rheumatology and Clinical Immunology, University Medical Center Utrecht, Utrecht, The Netherlands.

Seung-Ki Kwok (SK)

Division of Rheumatology, Department of Internal Medicine, College of Medicine, Seoul St Mary's Hospital, The Catholic University of Korea, Seoul, South Korea.

Marika Kvarnstrom (M)

Division of Rheumatology, Department of Medicine, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.

Sonja Praprotnik (S)

Department of Rheumatology, University Medical Centre, Ljubljana, Slovenia.

Damien Sene (D)

Département de Médecine Interne, Hôpital Lariboisière, Université Paris VII, Assistance Publique-Hôpitaux de Paris, Paris, France.

Roberto Gerli (R)

Rheumatology Unit, Department of Medicine, University of Perugia, Perugia, Italy.

Roser Solans (R)

Department of Internal Medicine, Hospital Vall d'Hebron, Barcelona, Spain.

Maureen Rischmueller (M)

Department of Rheumatology, The Queen Elizabeth Hospital, Discipline of Medicine, University of Adelaide, South Australia, Australia.

Thomas Mandl (T)

Department of Rheumatology, Skane University Hospital Malmö, Lund University, Malmö, Sweden.

Yasunori Suzuki (Y)

Division of Rheumatology, Kanazawa University Hospital, Kanazawa, Ishikawa, Japan.

David Isenberg (D)

Centre for Rheumatology, Division of Medicine, University College London, London, UK.

Valeria Valim (V)

Department of Medicine, Federal University of Espírito Santo, Vitória, Brazil.

Piotr Wiland (P)

Department of Rheumatology and Internal Medicine, Wroclaw Medical Hospital, Wroclaw, Poland.

Gunnel Nordmark (G)

Rheumatology, Department of Medical Sciences, University of Uppsala, Uppsala, Sweden.

Guadalupe Fraile (G)

Department of Internal Medicine, Hospital Ramón y Cajal, Madrid, Spain.

Hendrika Bootsma (H)

Department of Rheumatology & Clinical Immunology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.

Hideki Nakamura (H)

Department of Immunology and Rheumatology, Division of Advanced Preventive Medical Sciences, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.

Roberto Giacomelli (R)

Clinical Unit of Rheumatology, School of Medicine, University of L'Aquila, L'Aquila, Italy.

Valerie Devauchelle-Pensec (V)

Rheumatology Department, Brest University Hospital, Brest, France.

Benedikt Hofauer (B)

Otorhinolaryngology / Head and Neck Surgery, University Medical Center Freiburg, Freiburg, Germany.

Michele Bombardieri (M)

Centre for Experimental Medicine and Rheumatology, Queen Mary University of London, London, UK.

Virginia Fernandes Moça Trevisani (VFM)

Federal University of São Paulo, Sao Paulo, Brazil.

Daniel Hammenfors (D)

Section for Rheumatology, Department of Clinical Science, University of Bergen, Bergen, Norway.
Department of Rheumatology, Haukeland University Hospital, Bergen, Norway.

Sandra G Pasoto (SG)

Rheumatology Division, Hospital das Clinicas, Faculdade de Medicina da Universidade de Sao Paulo (HCFMUSP), Sao Paulo, Brazil.

Soledad Retamozo (S)

Instituto De Investigaciones En Ciencias De La Salud (INICSA), Universidad Nacional de Córdoba (UNC), Cordoba, Argentina.
Department of Rheumatology, Instituto Modelo de Cariología Privado S.R.L, Instituto Universitario de Ciencias Biomídicas de Córdoba, Cordoba, Argentina.

Tamer A Gheita (TA)

Rheumatology Department, Kasr Al Ainy School of Medicine, Cairo University, Cairo, Egypt.

Fabiola Atzeni (F)

IRCCS Galeazzi Orthopedic Institute, Milan, Italy.
Rheumatology Unit, University of Messina, Messina, Italy.

Jacques Morel (J)

Department of Rheumatology, CHU Montpellier, University of Montpellier, Montpellier, France.

Cristina Vollenweider (C)

Department of Rheumatology, German Hospital, Buenos Aires, Argentina.

Margit Zeher (M)

Division of Clinical Immunology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.

Kathy Sivils (K)

Arthritis and Clinical Immunology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, USA.

Bei Xu (B)

Department of Rheumatology and Immunology, Anhui Provincial Hospital, Hefei, China.

Stefano Bombardieri (S)

Rheumatology Unit, University of Pisa, Pisa, Italy.

Pulukool Sandhya (P)

Department of Clinical Immunology & Rheumatology, Christian Medical College & Hospital, Vellore, India.

Salvatore De Vita (S)

Clinic of Rheumatology, Department of Medical Area, University Hospital 'Santa Maria della Misericordia', Udine, Italy.

Antonina Minniti (A)

Department of Internal Medicine and Medical Specialties, Rheumatology Clinic, Sapienza University of Rome, Rome, Italy.

Jorge Sánchez-Guerrero (J)

Immunology and Rheumatology Department, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, México City, Mexico.

Levent Kilic (L)

Department of Internal Medicine, Hacettepe University, Faculty of Medicine, Ankara, Turkey.

Eefje van der Heijden (E)

Department of Rheumatology and Clinical Immunology, University Medical Center Utrecht, Utrecht, The Netherlands.

Sung-Hwan Park (SH)

Division of Rheumatology, Department of Internal Medicine, College of Medicine, Seoul St Mary's Hospital, The Catholic University of Korea, Seoul, South Korea.

Marie Wahren-Herlenius (M)

Division of Rheumatology, Department of Medicine, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.

Xavier Mariette (X)

Center for Immunology of Viral Infections and Autoimmune Diseases, Assistance Publique - Hôpitaux de Paris, Hôpitaux Universitaires Paris-Sud, Le Kremlin-Bicêtre, Université Paris Sud, INSERM, Paris, France.

Manuel Ramos-Casals (M)

Sjögren Syndrome Research Group (AGAUR), Laboratory of Autoimmune Diseases Josep Font, IDIBAPS-CELLEX, Department of Autoimmune Diseases, ICMiD, University of Barcelona, Hospital Clínic, Barcelona, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH